New research from the University of Virginia School of Medicine speaks to the benefits of a COVID-19 booster.
The new findings shed light on how mRNA boosters – both Pfizer and Moderna – affect the durability of our antibodies to COVID-19. A booster, the researchers report, made for longer-lasting antibodies for all recipients, even those who have recovered from a COVID-19 infection.
source https://www.pharmatutor.org/pharma-news/2022/covid-19-booster-increases-durability-of-antibody-response
No comments:
Post a Comment